Internal Medicine, Rheumatology · Jackson, MI
NPI
1528447968
Since 2015
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
205 N East Ave
Jackson, MI, 49201
Phone (517) 788-4800
Groups this clinician bills Medicare through
Medicare paid, 2024
$59K
1,921 services
Medicare patients, 2024
324
Average age 73
Drug cost, 2024
$5.5M
3,506 prescriptions
Company payments, 2025
$284
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Hazem Zebda was code 99214 (office e&m - established), 627 times for 299 patients. In total Hazem Zebda billed 1,921 services in 16 codes, and Medicare paid $59K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-10-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 627 | 299 | $63.36 | $40K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 447 | 246 | $11.91 | $5,322 |
| 99204 Office E&M - New | Office | 25 | 25 | $79.21 | $1,980 |
| 20611 Joint Injection | Office | 22 | 15 | $49.42 | $1,087 |
| 99443 Telephone Services | Office | 18 | 15 | $78.86 | $1,420 |
| 99215 Office E&M - Established | Office | 11 | 11 | $98.01 | $1,078 |
By year: 2022 $36K for 498 services; 2023 $60K for 1,704 services; 2024 $59K for 1,921 services.
Medicare prescription drug claims, 2024
In 2024, the drug Hazem Zebda prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 596 prescriptions and refills. In total Hazem Zebda wrote 3,506 Medicare prescriptions that cost $5.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Methotrexate Methotrexate Sodium | 596 | 1,430 | 183 | $24K |
| Hydroxychloroquine Sulfate Generic | 559 | 1,564 | 189 | $36K |
| Prednisone Generic | 239 | 461 | 84 | $2,206 |
| Sulfasalazine Generic | 162 | 407 | 51 | $7,258 |
| Leflunomide Generic | 127 | 319 | 39 | $11K |
| Xeljanz Xr Tofacitinib Citrate | 124 | 124 | 16 | $675K |
| Sulfasalazine Dr Sulfasalazine | 121 | 305 | 31 | $9,131 |
| Humira(Cf) Pen Adalimumab | 117 | 117 | 13 | $1.0M |
| Allopurinol Generic | 96 | 284 | 27 | $1,637 |
| Rinvoq Upadacitinib | 95 | 95 | 11 | $587K |
| Folic Acid Generic | 80 | 214 | 25 | $487 |
| Duloxetine Hcl Generic | 76 | 190 | 20 | $2,365 |
| Cyclobenzaprine Hcl Generic | 71 | 116 | 20 | $1,347 |
| Colchicine Generic | 66 | 160 | 21 | $3,509 |
| Meloxicam Generic | 65 | 129 | 26 | $323 |
Brand drugs: - claims; generic drugs: 2,299 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Hazem Zebda $284 ($284 in general payments such as food, travel and fees) from 2 companies. The largest payer was Amgen Inc. with $159.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.